If IL-6 and Il-8 are directly involved in autocrine and paracrine loops that stimulate uptake and degradation of LDL by AML cells then this could be used as a therapeutic target for antibodies to these cytokines. This evidence concerns the gene IL6 and acute myeloid leukemia.